GILD Chart
- 52-Week Range: $57.19 - $72.71
- Market Capitalization: $78.23B
- Short Percentage: 0%
- Target Price: $69.52
- Shares Outstanding: 1.25B
- Next Earnings: Feb 3
Catalysts
CategoryCatalyst
Earnings
GILD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Top Stocks To Help Prepare For A Recession - We Recommend Gilead SciencesSeeking Alpha | May 2nd
- Gilead Sciences, Inc. (GILD) CEO Daniel O'Day on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | April 28th
- How Gilead is positioning its COVID-19 drug against newer antivirals like PaxlovidMarket Watch | April 27th
Company Info
Website: https://www.gilead.com
Address: 333 Lakeside Drive, Foster City, CA, United States, 94404
Sector: Healthcare
Industry: Drug Manufacturers—General
Full time employees: 14,400
Address: 333 Lakeside Drive, Foster City, CA, United States, 94404
Sector: Healthcare
Industry: Drug Manufacturers—General
Full time employees: 14,400
$GILD what calls are you guys jacked to the tits on?
$GILD back to business
$GILD the price is wrong
$GILD Be patient !!
$GILD There is nothing wrong with a decent pullback
$GILD time to make a big run Monday morning. Let's get it! ????????????????????????????
$GILD Holding
$GILD Many many bears